ERIN WALSH: Open Payments
NPI 1346810272 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,932 in 156 payments from 14 companies in 2025. Trend: 2023 $2,433 · 2024 $1,780 · 2025 $2,932
Food & beverage: $2,712Education: $220
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 39 | $684 |
| Neurocrine BioSciences, Inc. | 20 | $378 |
| Axsome Therapeutics, Inc. | 23 | $328 |
| Teva Pharmaceuticals USA, Inc. | 7 | $290 |
| Vanda Pharmaceuticals Inc. | 17 | $272 |
| Alkermes, Inc. | 12 | $254 |
| ABBVIE INC. | 20 | $250 |
| Almatica Pharma LLC | 5 | $108 |
| ACADIA Pharmaceuticals Inc | 1 | $101 |
| Bausch Health US, LLC | 3 | $67 |
Products named: CAPLYTA, INGREZZA, Auvelity, FANAPT, ARISTADA, VRAYLAR, LOREEV XR, NUPLAZID.
Industry payments across PA — which companies pay providers there.
